The effect of phoenix Dactylifera supplementary on fatigue in patients with multiple sclerosis
Phase 3
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20230706058689N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Having a history of MS for at least 3 months (based on the information in the patient's file)
Age 18 to 60 years
Absence of food and drug allergy (date products)
Obtaining a score of 28 or more in severe measurement (FSS)
Obtaining informed consent
Absence of pregnancy (pregnancy during the study period or decision to become pregnant at the beginning of the study)
Exclusion Criteria
The use of antidepressants
The use of other medications effective in relieving fatigue (Ritalin, Pemoline, Amantadine)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue score based on the Fatigue Severity Scale (FSS). Timepoint: Measuring the severity of fatigue at the beginning (before the start of the intervention) and 6 weeks after the start of the intervention. Method of measurement: Fatigue severity scale Questionnaire.
- Secondary Outcome Measures
Name Time Method